This inventor holds 6 USPTO granted patents and 4 published patent applications. Top assignees: The Brigham and Women's Hospital, Inc., Arizona State University, The General Hospital Corporation. Active years: 2006-2025.
Company Filing History:



Years Active: 2006-2025
Title: Innovations by Daniel Cramer in Ovarian Cancer Detection
Introduction
Daniel Cramer is a notable inventor based in Chestnut Hill, MA (US), recognized for his significant contributions to the field of medical diagnostics. He holds a total of six patents, focusing primarily on the early detection of ovarian cancer through innovative biomarker technologies. His work has the potential to greatly enhance the accuracy and timeliness of cancer diagnoses.
Latest Patents
Cramer's latest patents include groundbreaking compositions and methods relating to a panel of autoantibody biomarkers for the early detection of ovarian cancer. These compositions encompass antigen biomarkers coupled to a substrate, with the biomarkers selected from a specific group that includes ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3. This innovative approach aims to improve the diagnostic process for ovarian cancer, potentially leading to earlier and more effective treatment options.
Career Highlights
Throughout his career, Daniel Cramer has worked with prestigious institutions such as Brigham and Women's Hospital and Arizona State University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research and diagnostics.
Collaborations
Cramer has collaborated with notable colleagues, including Bin Ye and Samuel C Mok. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the medical community.
Conclusion
Daniel Cramer's innovative work in the field of ovarian cancer detection exemplifies the importance of research and development in medical diagnostics. His contributions through patents and collaborations continue to pave the way for advancements that could save lives.